Oncology

Epigenetic drugs may reduce viral reactivation of herpes and other viruses.

Scientists hone in on personalized treatments for patients with cancer.

Top news of the day from across the health care landscape.

An estimated 1.2 million American women would likely benefit from recommended genetic test to assess their risk of cancer.

The risk of developing liver cancer is similar with direct-acting antiviral drugs or interferon therapy for hepatitis C virus.

Alcohol consumption results in more than $150 million spent on breast cancer annually.

FDA to evaluate obinutuzumab (Gazyva) in combination with chemotherapy for patients with previously untreated follicular lymphoma.

Experimental drug shows evidence of lowering cholesterol, reducing risk of cardiovascular disease, and potentially treating lung cancer.

Fulvestrant is a hormonal therapy that targets the estrogen receptor and helps slow cancer growth.

A drug being explored as a cardiovascular disease treatment may also reduce the risk of lung cancer.

A decision on the approval of obinutuzumab is expected by December 23, 2017.

Top news of the day from across the health care landscape.

Hormone therapy is recommended to treat menopause symptoms, but is not recommended for breast cancer survivors.

Women who worked the night shift found to have a greater risk of developing breast cancer.

Breast cancer treatment may cause women to enter menopause prematurely.

Top news of the day from across the health care landscape.

A first-in-class selective retinoic acid receptor alpha agonist is being tested in phase 2 clinical trials for acute myeloid leukemia and myelodysplastic syndrome.

Novel first-in-class selective retinoic acid receptor alpha agonist inhibits tumor growth in acute myeloid leukemia.

T cell responses in different tumor models are fundamentally similar.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

Study finds greater rate of opioid prescribing among cancer survivors 10 or more years past their cancer diagnosis.

Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.

Understudied gene provides insight into how liver cancer cells gain the nutrition necessary to proliferate.

A first-in-class molecule was found to inhibit primary and recurrent breast cancer.

The novel strategy could be more effective and less toxic than current chemotherapy drugs treating alternative lengthening telomere cancers.

Carolyn Choate journeys 300 miles in a kayak to honor the pharmacologist who created the lifesaving aromatase inhibitor.

Top news of the week from Specialty Pharmacy Times.

Managing chronic pain after a cancer diagnosis remains a challenge.